|
1
|
Davies L, Ouellette M, Hunter M and Welch
HG: The increasing incidence of small thyroid cancers: Where are
the cases coming from? Laryngoscope. 120:2446–2451. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schneider DF and Chen H: New developments
in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin.
63:374–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burman KD and Wartofsky L: Clinical
Practice. Thyroid nodules. N Engl J Med. 373:2347–2356. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hedinger C, Williams ED and Sobin LH: The
WHO histological classification of thyroid tumors: A commentary on
the second edition. Cancer. 63:908–911. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
American Thyroid Association Guidelines
Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, ;
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ,
Mazzaferri EL, McIver B, Pacini F, et al: Revised American Thyroid
Association management guidelines for patients with thyroid nodules
and differentiated thyroid cancer. Thyroid. 19:1167–1214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crippa S, Mazzucchelli L, Cibas ES and Ali
SZ: The Bethesda System for reporting thyroid fine-needle
aspiration specimens. Am J Clin Pathol. 134:343–345. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zablotska LB, Nadyrov EA, Polyanskaya ON,
McConnell RJ, O'Kane P, Lubin J, Hatch M, Little MP, Brenner AV,
Veyalkin IV, et al: Risk of thyroid follicular adenoma among
children and adolescents in Belarus exposed to iodine-131 after the
Chornobyl accident. Am J Epidemiol. 182:781–790. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dutta-Roy AK: Cellular uptake of
long-chain fatty acids: Role of membrane-associated
fatty-acid-binding/transport proteins. Cell Mol Life Sci.
57:1360–1372. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nickerson JG, Alkhateeb H, Benton CR,
Lally J, Nickerson J, Han XX, Wilson MH, Jain SS, Snook LA, Glatz
JF, et al: Greater transport efficiencies of the membrane fatty
acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1
and differential effects on fatty acid esterification and oxidation
in rat skeletal muscle. J Biol Chem. 284:16522–16530. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santos CR and Schulze A: Lipid metabolism
in cancer. FEBS J. 279:2610–2623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Souza RJ, Mente A, Maroleanu A, Cozma
AI, Ha V, Kishibe T, Uleryk E, Budylowski P, Schünemann H, Beyene J
and Anand SS: Intake of saturated and trans unsaturated fatty acids
and risk of all-cause mortality, cardiovascular disease, and type 2
diabetes: Systematic review and meta-analysis of observational
studies. BMJ. 351:h39782015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lagrou A, Dierick W, Christophe A and
Verdonk G: Lipid composition of normal and hypertrophic bovine
thyroids. Lipids. 9:870–875. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Butte NF, Puyau MR, Vohra FA, Adolph AL,
Mehta NR and Zakeri I: Body size, body composition, and metabolic
profile explain higher energy expenditure in overweight children. J
Nutr. 137:2660–2667. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berg JP, Glattre E, Haldorsen T, Høstmark
AT, Bay IG, Johansen AF and Jellum E: Longchain serum fatty acids
and risk of thyroid cancer: A population-based case-control study
in Norway. Cancer Causes Control. 5:433–439. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Qiu L, He C, Wang Y, Liu Y, Zhang
D and Li Z: Serum unsaturated free fatty acids: A potential
biomarker panel for differentiating benign thyroid diseases from
thyroid cancer. J Cancer. 6:1276–1281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao Z, Yin P, Su D, Peng Z, Zhou L, Ma L,
Guo W, Ma L, Xu G, Shi J and Jiao B: Serum metabolic profiling and
features of papillary thyroid carcinoma and nodular goiter. Mol
Biosyst. 7:2608–2614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim KM, Jung BH, Lho DS, Chung WY, Paeng
KJ and Chung BC: Alteration of urinary profiles of endogenous
steroids and polyunsaturated fatty acids in thyroid cancer. Cancer
Lett. 202:173–179. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leng J, Guan Q, Sun T, Wu Y, Cao Y and Guo
Y: Application of isotope-based carboxy group derivatization in
LC-MS/MS analysis of tissue free-fatty acids for thyroid carcinoma.
J Pharm Biomed Anal. 84:256–262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo S, Wang Y, Zhou D and Li Z:
Significantly increased monounsaturated lipids relative to
polyunsaturated lipids in six types of cancer microenvironment are
observed by mass spectrometry imaging. Sci Rep. 4:59592014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chinese Society of Endocrinology, Chinese
Medical Association, . China Thyroid Disease Diagnosis and
Treatment Guidelines. Zhonghua Nei Ke Za Zhi. 47:867–868. 2008.(In
Chinese).
|
|
25
|
Davies L and Welch HG: Current thyroid
cancer trends in the United States. JAMA Otolaryngol Head Neck
Surg. 140:317–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoang JK, Nguyen XV and Davies L:
Overdiagnosis of thyroid cancer: Answers to five key questions.
Acad Radiol. 22:1024–1029. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kolonel LN, Hankin JH, Wilkens LR,
Fukunaga FH and Hinds MW: An epidemiologic study of thyroid cancer
in Hawaii. Cancer Causes Control. 1:223–234. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Glattre E, Haldorsen T, Berg JP, Stensvold
I and Solvoll K: Norwegian case-control study testing the
hypothesis that seafood increases the risk of thyroid cancer.
Cancer Causes Control. 4:11–16. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Horn-Ross PL, Morris JS, Lee M, West DW,
Whittemore AS, McDougall IR, Nowels K, Stewart SL, Spate VL, Shiau
AC and Krone MR: Iodine and thyroid cancer risk among women in a
multiethnic population: the Bay Area Thyroid Cancer Study. Cancer
Epidemiol Biomarkers Prev. 10:979–985. 2001.PubMed/NCBI
|
|
30
|
Wang Yilong: Study of Wenzhou food
culture. Zhejiang Ocean University; 2014, (In Chinese).
|
|
31
|
Uddin S, Siraj AK, Al-Rasheed M, Ahmed M,
Bu R, Myers JN, Al-Nuaim A, Al-Sobhi S, Al-Dayel F, Bavi P, et al:
Fatty acid synthase and AKT pathway signaling in a subset of
papillary thyroid cancers. J Clin Endocrinol Metab. 93:4088–4097.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calder PC: Polyunsaturated fatty acids,
inflammation, and immunity. Lipids. 36:1007–1024. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hegedus L: Clinical practice. The thyroid
nodule. N Engl J Med. 351:1764–1771. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bjoro T, Holmen J, Kruger O, Midthjell K,
Hunstad K, Schreiner T, Sandnes L and Brochmann H: Prevalence of
thyroid disease, thyroid dysfunction and thyroid peroxidase
antibodies in a large, unselected population. The Health Study of
Nord-Trondelag (HUNT). Eur J Endocrinol. 143:639–647. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Prummel MF and Wiersinga WM: Thyroid
peroxidase autoantibodies in euthyroid subjects. Best Pract Res
Clin Endocrinol Metab. 19:1–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fiore E and Vitti P: Serum TSH and risk of
papillary thyroid cancer in nodular thyroid disease. J Clin
Endocrinol Metab. 97:1134–1145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu Y, Zheng X, Qiu Y, Jia W, Wang J and
Yin S: Distinct metabolomic profiles of papillary thyroid carcinoma
and benign thyroid adenoma. J Proteome Res. 14:3315–3321. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen JH, Perry CJ, Tsui YC, Staron MM,
Parish IA, Dominguez CX, Rosenberg DW and Kaech SM: Prostaglandin
E2 and programmed cell death 1 signaling coordinately impair CTL
function and survival during chronic viral infection. Nat Med.
21:327–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nikiforova MN, Lynch RA, Biddinger PW,
Alexander EK, Dorn GW III, Tallini G, Kroll TG and Nikiforov YE:
RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid
tumors: Evidence for distinct molecular pathways in thyroid
follicular carcinoma. J Clin Endocrinol Metab. 88:2318–2326. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fugazzola L, Puxeddu E, Avenia N, Romei C,
Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S,
et al: Correlation between B-RAFV600E mutation and
clinico-pathologic parameters in papillary thyroid carcinoma: Data
from a multicentric Italian study and review of the literature.
Endocr Relat Cancer. 13:455–464. 2006. View Article : Google Scholar : PubMed/NCBI
|
